Kenbi closed a Series B round (amount undisclosed) in Feb 2024. The company is based in Berlin, Germany. Investors in the round: Achmea Innovation Fund, Helsana HealthInvest, SPFF Holding. Data as of 7 Aug 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
